Patent US4592995A successfully refreshed from Google Patents.
US4592995A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Reagent for streptococcal anti-esterase assay
Assignee: Sumitomo Pharma Co Ltd
•
Filing: 1983-11-16
•
Granted: 1986-06-03
•
Expires: 2003-11-16
Abstract
Abstract A reagent for the determination of an antibody against an esterase from pathogenic streptococci, which comprises reagent 1: an esterase (a) from pathogenic streptococci, reagent 2: a protein (b) which is capable of binding to an antibody (d) against the esterase (a) and is bound to an insoluble carrier, and reagent 3: a reagent (c) for measuring an activity of the esterase (a), and a method for the determination of an antibody against an esterase from pathogenic streptococci. The reagent and method of the present invention are useful for diagnosis of various diseases caused by pathogenic streptococcal infections.
Inventors
- 👤 Seiki Hayano
- 👤 Kanae Yokogawa
- 👤 Shigeru Kurooka
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 12:33
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/34; C12Q1/44; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/554; G01N33/569; G01N33/56911; G01N33/56944; G01N33/573; G01N2333/00; G01N2333/195; G01N2333/315; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S435/975; Y10S436/00; Y10S436/828
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
134 words
A reagent kit for the quantitative determination of an antibody against an esterase from pathogenic streptococci in human blood serum, comprising: (a) a predetermined quantity of an esterase from pathogenic streptococci, said predetermined quantity being at least immunochemically equivalent to the quantity of said antibody to be determined; (b) a predetermined quantity of a protein-A, said protein-A being able to bind non-specifically to said antibody to be determined and being bound to an insoluble carrier, said predetermined quantity being at least immunochemically equivalent to the quantity of said antibody to be determined; and (c) a predetermined quantity of a substrate reagent that measures esterase activity, which is selected from the group consisting of S-acetylthiophenol, naphthylacetate and nitrophenylacetate, and said predetermined quantity being sufficient to measure quantitatively the esterase in an esterase-anti-esterase antibody-insoluble protein-A complex.
Claim 2
Dependent Claim
134 words
A reagent kit for the quantitative determination of an antibody against an esterase from pathogenic streptococci in human blood serum, comprising: (a) a predetermined quantity of an esterase from pathogenic streptococci, said predetermined quantity being at least immunochemically equivalent to the quantity of said antibody to be determined; (b) a predetermined quantity of a protein-A, said protein-A being able to bind non-specifically to said antibody to be determined and being bound to an insoluble carrier, said predetermined quantity being at least immunochemically equivalent to the quantity of said antibody to be determined; and (c) a predetermined quantity of a substrate reagent that measures esterase activity, which is selected from the group consisting of S-acetylthiophenol, naphthylacetate and nitrophenylacetate, and said predetermined quantity being sufficient to measure quantitatively the esterase in an esterase-anti-esterase antibody-insoluble protein-A complex.
Claim 3
Dependent Claim
32 words
The reagent kit of claim 1, wherein said esterase is selected from the group consisting of a type A-I esterase, a type A-II esterase, the type B esterase, and a mixture thereof.
Claim 4
Dependent Claim
33 words
The reagent kit of claim 1, wherein said insoluble carrier is selected from the group consisting of bacterial cell walls, glass beads, and a hydrophilic, insoluble molecular-sieve chromatographic medium, made by cross-linking dextran.
Claim 5
Dependent Claim
21 words
The reagent kit of claim 1, wherein said protein-A bound to an insoluble carrier is bacterial cell walls containing a protein-A.
Claim 6
Independent Claim
125 words
A method for the quantitative determination of an antibody against an esterase from pathogenic streptococci in human blood serum comprising: (a) adding at least an immunochemical euqivalent of an esterase from pathogenic streptococci to human blood serum containing said antibody to be determined; (b) adding to the mixture of step (a) at least an immunochemical equivalent of a protein-A, said protein-A being able to bind non-specifically to said antibody to be determined and being bound to an insoluble carrier to form an esterase-anti-esterase antibody-insoluble protein-A complex; (c) separating said complex from the mixture of step (b) by centrifugation; and (d) mesuring the activity of the esterase in said complex by using a substrate which is selected from the group consisting of S-acethylthiophenol, naphthylacetate and nitrophenlacetate.
Claim 7
Independent Claim
125 words
A method for the quantitative determination of an antibody against an esterase from pathogenic streptococci in human blood serum comprising: (a) adding at least an immunochemical euqivalent of an esterase from pathogenic streptococci to human blood serum containing said antibody to be determined; (b) adding to the mixture of step (a) at least an immunochemical equivalent of a protein-A, said protein-A being able to bind non-specifically to said antibody to be determined and being bound to an insoluble carrier to form an esterase-anti-esterase antibody-insoluble protein-A complex; (c) separating said complex from the mixture of step (b) by centrifugation; and (d) mesuring the activity of the esterase in said complex by using a substrate which is selected from the group consisting of S-acethylthiophenol, naphthylacetate and nitrophenlacetate.
Claim 8
Independent Claim
125 words
A method for the quantitative determination of an antibody against an esterase from pathogenic streptococci in human blood serum comprising: (a) adding at least an immunochemical euqivalent of a protein-A, said protein-A being able to bind non-specifically to said antibody to be determined and being bound to an insoluble carrier to human blood serum containing said antibody to be determined; (b) adding to the mixture of step (a) at least an immunochemical equivalent of an esterase from pathogenic streptococci to form an esterase-anti-esterase antibody-insoluble protein-A complex; (c) separating said complex from the mixture of step (b) by centrifugation; and (d) measuring the activity of the esterase in said complex by using a substrate which is selected from the group consisting of S-acethylthiophenol, naphthylacetate and nitrophenylacetate.
Claim 9
Independent Claim
125 words
A method for the quantitative determination of an antibody against an esterase from pathogenic streptococci in human blood serum comprising: (a) adding at least an immunochemical euqivalent of a protein-A, said protein-A being able to bind non-specifically to said antibody to be determined and being bound to an insoluble carrier to human blood serum containing said antibody to be determined; (b) adding to the mixture of step (a) at least an immunochemical equivalent of an esterase from pathogenic streptococci to form an esterase-anti-esterase antibody-insoluble protein-A complex; (c) separating said complex from the mixture of step (b) by centrifugation; and (d) measuring the activity of the esterase in said complex by using a substrate which is selected from the group consisting of S-acethylthiophenol, naphthylacetate and nitrophenylacetate.
Claim 10
Independent Claim
114 words
A method for the quantitative determination of an antibody against an esterase from pathogenic streptococci in human blood comprising: (a) adding simultaneously at least an immunochemical equivalent of an esterase from pathogenic streptococci and at least an immunochemical equivalent of a protein-A, said protein-A being able to bind non-specifically to said antibody to be determined and being bound to an insoluble carrier to human blood serum containing said antibody to be determined to form an esterase-anti-esterase antibody-insoluble protein-A complex; (b) separating said complex from the mixture of step (a) by centrifugation; and (c) measuring the activity of the esterase in said complex by using a substrate which is selected from S-acetylthiophenol, naphthylacetate and nitrophenylacetate.
Claim 11
Independent Claim
114 words
A method for the quantitative determination of an antibody against an esterase from pathogenic streptococci in human blood comprising: (a) adding simultaneously at least an immunochemical equivalent of an esterase from pathogenic streptococci and at least an immunochemical equivalent of a protein-A, said protein-A being able to bind non-specifically to said antibody to be determined and being bound to an insoluble carrier to human blood serum containing said antibody to be determined to form an esterase-anti-esterase antibody-insoluble protein-A complex; (b) separating said complex from the mixture of step (a) by centrifugation; and (c) measuring the activity of the esterase in said complex by using a substrate which is selected from S-acetylthiophenol, naphthylacetate and nitrophenylacetate.
References Cited (Backward Citations)
US3791932A
Cited
US3932221A
Cited
US3790447A
Cited
US4012285A
Cited
US4016043A
Cited
US4166767A
Cited
US4366242A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-06-02 | 1989-12-02 | 1990-06-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-06-02 | 1993-12-02 | 1994-06-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-06-02 | 1997-12-02 | 1998-06-03 | $7700.00 | Window Closed / Lapsed |